Ayari-Riabi, S.; Ben khalaf, N.; Bouhaouala-Zahar, B.; Verrier, B.; Trimaille, T.; Benlasfar, Z.; Chenik, M.; Elayeb, M.
Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major. Molecules 2022, 27, 8677.
https://doi.org/10.3390/molecules27248677
AMA Style
Ayari-Riabi S, Ben khalaf N, Bouhaouala-Zahar B, Verrier B, Trimaille T, Benlasfar Z, Chenik M, Elayeb M.
Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major. Molecules. 2022; 27(24):8677.
https://doi.org/10.3390/molecules27248677
Chicago/Turabian Style
Ayari-Riabi, Sana, Noureddine Ben khalaf, Balkiss Bouhaouala-Zahar, Bernard Verrier, Thomas Trimaille, Zakaria Benlasfar, Mehdi Chenik, and Mohamed Elayeb.
2022. "Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major" Molecules 27, no. 24: 8677.
https://doi.org/10.3390/molecules27248677
APA Style
Ayari-Riabi, S., Ben khalaf, N., Bouhaouala-Zahar, B., Verrier, B., Trimaille, T., Benlasfar, Z., Chenik, M., & Elayeb, M.
(2022). Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major. Molecules, 27(24), 8677.
https://doi.org/10.3390/molecules27248677